Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FL0C6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,187
Award facts
- Contract value 100% obligated
- $29,187.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,187.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count units). The delivery order, issued without set-aside designation, reflects DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement and was completed on October 28, 2025. As the sole awardee with no identified subcontractors, DMS Pharmaceutical Group will deliver this oncology pharmaceutical directly to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, designated SPE2DR with a $499.999 billion ceiling and completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products to support recurring medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across multiple delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FL0C6?
SPE2DB26FL0C6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FL0C6 worth?
The government has obligated $29,187 on SPE2DB26FL0C6.
Is contract SPE2DB26FL0C6 an order under another contract?
Yes. SPE2DB26FL0C6 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB26FL0C6 competed?
The extent of competition for SPE2DB26FL0C6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award